Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Балканфарма-Дупница" АДfiledCritical"Балканфарма-Дупница" АД
Priority to BG102167ApriorityCriticalpatent/BG62727B1/en
Publication of BG102167ApublicationCriticalpatent/BG102167A/en
Publication of BG62727B1publicationCriticalpatent/BG62727B1/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
The method can be used in the pharmaceutical industry. Itachieves a high yield over 96%, reduces the time of thetechnological process, reduces the quantity of the waste productsand turns out pure product which without any additionalpurification can be introduced in pharmaceutical forms. The methodconsists in direct reaction between DL-asparginic acid and powderiron in water medium, with boiling in nitrogen atmosphere.1 claim
BG102167A1998-01-091998-01-09Method for the preparation of ferrous-bis-dl-aspartate
BG62727B1
(en)
Diphenyl-piperidine butanamides as glycine transport inhibitors, process for producing them, use of them for producing medicaments and the pharmaceutical compositions containing them
Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria, pharmaceutical compositions containing them and process for their production
Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them